page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79
page 80
page 81
page 82
page 83
page 84
page 85
page 86
page 87
page 88
page 89
page 90
page 91
page 92
page 93
page 94
page 95
page 96
page 97
page 98
page 99
page 100
page 101
page 102
page 103
page 104
page 105
page 106
page 107
page 108
page 109
page 110
page 111
page 112
page 113
page 114
page 115
page 116
page 117
page 118
page 119
page 120
page 121
page 122
page 123
page 124
page 125
page 126
page 127
page 128
page 129
page 130
page 131
page 132
page 133
page 134
page 135
page 136
page 137
page 138
page 139
page 140
page 141
page 142
page 143
page 144
page 145
page 146
page 147
page 148
page 149
page 150
page 151
page 152
page 153
page 154
page 155
page 156
page 157
page 158
page 159
page 160
page 161
page 162
page 163
page 164
page 165
page 166
page 167
page 168
page 169
page 170
page 171
page 172
page 173
page 174
page 175
page 176
page 177
page 178
page 179
page 180
page 181
page 182
page 183
page 184
page 185
page 186

UKINNOVATION UK83 Healthcare RAUMEDIC UK LTD tomising materials to exact customer requirements and customer- specific developments. With available extrusion techniques we are able to pro-duce multilayer tubing with up to four different materials, as well as the production of micro tubing with radio-paque stripes or the production of multi lumen tubings with up to 13 lumens. In the field of micro extrusion RAUMEDIC produces tubing with a dimension of 0.10 mm and a wall thickness of 0.04mm. This corresponds to the thickness of a human hair ( 0.04 mm - 0.12 mm). RAUMEDIC injection moulding stands for smallest dimensions, tightest tolerances and crucially functional requirement for individual customer needs. RAUMEDIC annually produces several million moulded parts with weights between 4 mg and 200 g. RAUMEDIC's two shot component injection moulding techniques, over- mould-ing to tubing as well as fully automated assembly systems enables RAUMEDIC to produce complex customer spe-cific medical devices. For further processing of our tubings and components RAUMEDIC has wide ranging assembly possibilities, eg punching, printing, thermoforming, assembly/ bonding, packaging and microchip technology. Our product port-folio varies from common cut length, tubing sets and catheters to electronic measuring instruments. In close cooperation to physicians RAUMEDIC develops and manufactures high precision pressure measure sys-tems with microchip technology and a wide range of accessories for the indication fields Neuromonitoring, Urology, Gastronenterology, and Traumatology. Finally, RAUMEDIC can offer you a one- stop develop-ment and manufacturing programme for medical tub-ing, injection moulding and full contract manufacturing services. Our engineers will work with you to advise on materials, design and construction, together with pack-aging and sterilisation. The service includes full project management and commercial support for the project, drawing up full validation protocols and quality plans for ongoing testing of the product. We are able to offer full regulatory support and documentation to enable you to CE mark your medical device. For more information, contact: RAUMEDIC UK Hill Court, Walford Ross on Wye Herefordshire, HR9 5QN 0044 7785714815 www. raumedic. com info@ raumedic. com

84INNOVATION UKINNOVATION Healthcare MEDITROX/ STERITROX LTD UK infection- control professionals are constantly strug-gling to meet the day- to- day demands that modern hospital environments present. With ever- increasing pressure to improve overall hygiene levels, reduce cross- infection levels, and maintain patient and staff safety while working to strict budgets, the brief is not an easy one. To be successful, infection- control management need to deploy integrated strategies that protect patients and the hospital environment alike. In typical hospital environments, the infection- control community has relied heavily on well- applied surface decontamination as a first line of defence against cross-infection. Though cheap and effective where they are applied, they leave many important areas untouched as potential infection hotspots. In addition, this strategy relies on the diligence of the cleaning staff on a regular basis to ensure effectiveness, something that cannot be easily controlled. As a result, the infection- control community has started to explore the possibilities of deploying a decontamina-tion strategy that tackles the whole environment with a degree of automation. Whole room decontamination ( WRD) has a number of advantages in that all the surfaces in a target room are treated ( bed, walls, ceiling etc) ensuring no infection hotspots are missed. In addition, the air in the target area is also treated, ensuring that any air- borne pathogens are also destroyed. This is typically very useful when attempting to combat airborne pathogens such as Norovirus and influenza. Early WRD systems have typically been reserved for emer-gency situations where infection outbreaks need to be brought under control. Though effective, the approach is typically time consuming (> 120 minutes per applica-tion) and needs sophisticated human supervision to ensure that the process is safely deployed. This is time and resource that overloaded infection- control teams cannot afford. In the past few months, a new generation of routine WRD systems have just started to be evaluated by thought leaders in the infection- control community. Routine WRD works on the assumption that rooms get treated regularly to ensure that there is never an environmental build- up of the pathogens to facilitate a cross infection. Latest strategies for effective infection control in hospital environments by Mark Hamilton, Business Unit Director of Meditrox LEFT: Mark Hamilton RIGHT: Meditrox 47